Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 4 1Phase 3 1Phase 1/2 1

Status

Recruiting 3Unknown 1Not yet recruiting 1

Sponsor Class

OTHER 678NIH 88INDUSTRY 70NETWORK 58OTHER_GOV 5

Study Type

Interventional 5

Sponsor

Cancer Type

Lymphoid 12Breast 6Other hematologic neoplasm 5Plasma cell 4Other solid neoplasm 2Myeloid 2Sarcoma 1Head & Neck 1Dermatologic 1

Conditions

Leukemia 3Myelodysplastic Syndromes 2Leukemia, Myeloid, Acute 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasms, Plasma Cell 1Neoplasms 1Lymphoma, Non-Hodgkin 1Lymphoma 1Leukemia, Myelomonocytic, Juvenile 1Hodgkin Disease 1Hematologic Neoplasms 1Graft vs Host Disease 1

Interventions

fludarabine 5Cyclophosphamide 5Azacitidine 4Cytarabine 3venetoclax 2pegylated granulocyte colony-stimulating factor 2bisantrene 2Metformin 2Etoposide 2Dasatinib 2Clofarabine 2Busulfan 2vosaroxin 1treosulfan 1peginterferon alfa-2a 1nilotinib 1liposomal amphotericin B 1fludarabine phosphate 1defactinib 1decitabine and cedazuridine drug combination 1cedazuridine 1cc-486 1aldesleukin 1Zinc Sulfate 1Zinc 1Vitamin D 1Urination 1Tranexamic Acid 1Thiotepa 1Thalidomide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
OTHER_GOV × Cyclophosphamide × Other hematologic neoplasm × Clear all
NCT07120607 2025-08-13

Allogeneic CD7 CAR γδ T Cells Therapy Recurrent/Refractory Leukemia

Anhui Provincial Hospital

Phase 1 Not yet recruiting
9 enrolled
Other hematologic neoplasm

Leukemia

NCT06299462 2025-02-25

PTCy and ATG for MSD and MUD Transplants

Instituto Nacional de Cancer, Brazil

Phase 1/2 Recruiting
50 enrolled
LymphoidMyeloidOther hematologic neoplasm

Graft vs Host Disease, Hodgkin Disease, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05477589 2024-12-19

SCRIPT-AML

Vastra Gotaland Region

Phase 3 Recruiting
170 enrolled
Other hematologic neoplasm

Leukemia, Neoplasms, Leukemia, Myeloid, Acute

NCT05528887 2022-09-06

Study of CAR-T Cell Therapy in the Treatment of Relapsed/Refractory Hematological Malignancies

The Affiliated People's Hospital of Ningbo University

Phase 1 Recruiting
10 enrolled
LymphoidOther hematologic neoplasmPlasma cell

Leukemia, Lymphoma, Hematologic Neoplasms, Neoplasms, Plasma Cell

NCT01339988 2011-04-21

Busulfan and Cyclophosphamide Instead of Total Boby Irradiation (TBI) and Cyclophosphamide for Hematological Malignancies Hematocrit (HCT)

Tel-Aviv Sourasky Medical Center

Phase 4 Unknown
10 enrolled
MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myelomonocytic, Juvenile

Data powered by HemOnc (CC BY 4.0) Colophon âš¡